Yang et al. [61] found that, in an AngII-induced HUVEC cell model, EGCG (5–25 μMol·L−1) restrained the Ang II-induced activation of p38 MAPK and JNK1/2 kinases and reduced AngII-induced endothelial dysfunction. Here, AGT is linked to endothelial dysfunction.